Dr Reddys Laboratories RDY
NYSE RDY
$12.25 +0.01 (+0.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dr Reddys Laboratories (RDY) Amortizatization of Intangibles (2012)

Updated

Dr Reddys Laboratories' Amortizatization of Intangibles came in at $433 million for the quarter ended Jun 30, 2012.

Analysis

Dr Reddys Laboratories (RDY) Amortizatization of Intangibles (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Dr Reddys Laboratories 10.22 Bn 9.41 Bn 396.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 433.00 Mn
API Access

Dr Reddys Laboratories Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=RDY&period=max&api_key=YOUR_API_KEY